Cytokinetics | CYTK - Ebit

Stock Price
75.85
Daily Change
-2.79 -3.55%
Monthly
15.94%
Yearly
144.68%
Q2 Forecast
74.33

Cytokinetics reported $-181.23M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Acadia Pharmaceuticals USD -4.62M 22.01M Mar/2026
Amgen USD 3.83B 130M Mar/2026
Arca Biopharma USD -34.43M 326K Dec/2025
Bayer EUR 3.53B 2.42B Mar/2026
Biogen USD 514.3M 502.8M Mar/2026
Brainstorm Cell Therapeutics USD -2.05M 526K Sep/2025
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cytokinetics USD -181.23M 2.86M Mar/2026
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Exelixis USD 251.34M 15.43M Mar/2026
Geron USD -236K 10.55M Mar/2026
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
Ionis Pharmaceuticals USD -118M 97M Mar/2026
Ligand Pharmaceuticals USD 60.33M 1.76M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Novartis USD 4.18B 118M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Regeneron Pharmaceuticals USD 744.8M 153.8M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026